The glycosyltransferase EXTL2 promotes proteoglycan deposition and injurious neuroinflammation following demyelination

[1]  J. Silver,et al.  Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis , 2018, Nature Communications.

[2]  V. Yong,et al.  The extracellular matrix: Focus on oligodendrocyte biology and targeting CSPGs for remyelination therapies , 2018, Glia.

[3]  M. Simons,et al.  Mononuclear phagocytes locally specify and adapt their phenotype in a multiple sclerosis model , 2018, Nature Neuroscience.

[4]  V. Yong,et al.  Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis , 2018, Brain : a journal of neurology.

[5]  J. Silver,et al.  Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury , 2018, Journal of Neuroinflammation.

[6]  M. Noda,et al.  Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation , 2017, PloS one.

[7]  Christina K. Chan,et al.  Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation* , 2016, The Journal of Biological Chemistry.

[8]  V. Yong,et al.  An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination , 2016, Nature Communications.

[9]  Lixia Li,et al.  The regulation of immune cell trafficking by the extracellular matrix. , 2015, Current opinion in cell biology.

[10]  D. Grinberg,et al.  EXTL2 and EXTL3 inhibition with siRNAs as a promising substrate reduction therapy for Sanfilippo C syndrome , 2015, Scientific Reports.

[11]  W. Stallcup,et al.  NG2-proteoglycan-dependent contributions of oligodendrocyte progenitors and myeloid cells to myelin damage and repair , 2015, Journal of Neuroinflammation.

[12]  Ying-ping Deng,et al.  Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury , 2015, Experimental Neurology.

[13]  V. Yong,et al.  Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin , 2015, Journal of visualized experiments : JoVE.

[14]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[15]  A. Suttkus,et al.  Aggrecan, link protein and tenascin-R are essential components of the perineuronal net to protect neurons against iron-induced oxidative stress , 2014, Cell Death and Disease.

[16]  E. Bradbury,et al.  Review: Manipulating the extracellular matrix and its role in brain and spinal cord plasticity and repair , 2014, Neuropathology and applied neurobiology.

[17]  V. Yong,et al.  Pathophysiology of the brain extracellular matrix: a new target for remyelination , 2013, Nature Reviews Neuroscience.

[18]  M. Pirinen,et al.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.

[19]  H. Kitagawa,et al.  EXTL2, a Member of the EXT Family of Tumor Suppressors, Controls Glycosaminoglycan Biosynthesis in a Xylose Kinase-dependent Manner* , 2013, The Journal of Biological Chemistry.

[20]  Scott Sloka,et al.  Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination , 2012, Annals of neurology.

[21]  M. Fehlings,et al.  Chondroitinase and Growth Factors Enhance Activation and Oligodendrocyte Differentiation of Endogenous Neural Precursor Cells after Spinal Cord Injury , 2012, PloS one.

[22]  D. Osterhout,et al.  The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes , 2011, Journal of neurochemistry.

[23]  D. Stelzner,et al.  Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells , 2011, Experimental Neurology.

[24]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[25]  J. Newcombe,et al.  Extracellular Matrix in Multiple Sclerosis Lesions: Fibrillar Collagens, Biglycan and Decorin are Upregulated and Associated with Infiltrating Immune Cells , 2010, Brain pathology.

[26]  S. Byers,et al.  Gene silencing of EXTL2 and EXTL3 as a substrate deprivation therapy for heparan sulphate storing mucopolysaccharidoses , 2010, European Journal of Human Genetics.

[27]  Jessica K. Alexander,et al.  Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord , 2009, The Journal of Neuroscience.

[28]  Wan-Wan Lin,et al.  Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis , 2009, Nature.

[29]  Fei Tan,et al.  Chondroitin-4-sulfation negatively regulates axonal guidance and growth , 2008, Journal of Cell Science.

[30]  Michal Schwartz,et al.  America , 2012 .

[31]  S. McMahon,et al.  Chondroitinase ABC Promotes Sprouting of Intact and Injured Spinal Systems after Spinal Cord Injury , 2006, The Journal of Neuroscience.

[32]  J. Silver,et al.  Chondroitinase ABC Digestion of the Perineuronal Net Promotes Functional Collateral Sprouting in the Cuneate Nucleus after Cervical Spinal Cord Injury , 2006, The Journal of Neuroscience.

[33]  A. Zurn,et al.  Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone , 2005, Neuroscience.

[34]  H. M. Geller,et al.  Chondroitin 6‐sulphate synthesis is up‐regulated in injured CNS, induced by injury‐related cytokines and enhanced in axon‐growth inhibitory glia , 2005, The European journal of neuroscience.

[35]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Tuszynski,et al.  The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury , 2003, Experimental Neurology.

[37]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[38]  James W. Fawcett,et al.  Chondroitinase ABC promotes functional recovery after spinal cord injury , 2002, Nature.

[39]  Mark H. Tuszynski,et al.  NG2 Is a Major Chondroitin Sulfate Proteoglycan Produced after Spinal Cord Injury and Is Expressed by Macrophages and Oligodendrocyte Progenitors , 2002, The Journal of Neuroscience.

[40]  J. Fawcett,et al.  Versican Is Upregulated in CNS Injury and Is a Product of Oligodendrocyte Lineage Cells , 2002, The Journal of Neuroscience.

[41]  R. Sobel,et al.  White Matter Extracellular Matrix Chondroitin Sulfate/Dermatan Sulfate Proteoglycans in Multiple Sclerosis , 2001, Journal of neuropathology and experimental neurology.

[42]  J. Fawcett,et al.  Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes , 2000, The Journal of Neuroscience.

[43]  K. Prydz,et al.  Synthesis and sorting of proteoglycans. , 2000, Journal of cell science.

[44]  H. Kitagawa,et al.  The Tumor Suppressor EXT-like Gene EXTL2 Encodes an α1, 4-N-Acetylhexosaminyltransferase That TransfersN-Acetylgalactosamine and N-Acetylglucosamine to the Common Glycosaminoglycan-Protein Linkage Region , 1999, The Journal of Biological Chemistry.